Follow-Up Study Suggests Potential Measure of Target Engagement

Follow-Up Study Suggests Potential Measure of Target Engagement
In this exciting study funded by The Cure Parkinson's Trust, Prof Tom Foltynie and colleagues published a report demonstrating how blood-based biomarkers could be used as objective measures of drug activity in the brain. The researchers analysed 'exosomes' - small brain cell-derived sacks - found in the blood samples of Parkinson's participants in the Exenatide Phase II clinical study, and ... read more
Source: Published on 2019-01-30